NCT06668298View on ClinicalTrials.gov

Clinical Study of G Protein Biased Μ - Opioid Receptor Agonist Oliceridine for Optimizing Postoperative Analgesia Under General Anesthesia

NANot yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Old Age

Interventions

DRUG

Oliceridine

The formula for postoperative analgesia pump is oliceridine 0.4mg · kg-1+tropisetron 10mg, mixed with physiological saline to 100ml.

DRUG

Sulfentanil

The analgesic regimen for the sufentanil group is sufentanil 2 µ g · kg-1+tropisetron 10mg, mixed with physiological saline to 100ml.

All Listed Sponsors

lead

Henan Provincial People's Hospital

OTHER

NCT06668298 - Clinical Study of G Protein Biased Μ - Opioid Receptor Agonist Oliceridine for Optimizing Postoperative Analgesia Under General Anesthesia | Biotech Hunter | Biotech Hunter